Biogen shares rise on sales of groundbreaking Alzheimer's drug Leqembi

Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher than expected sales of its groundbreaking Alzheimer’s drug Leqembi. Read more...

By: Quartz India

May 20 2024
59
4932 Views

This 'locked-in' risk management advisor gets his followers hyped about 'hammering spreadsheets' and quarterly meetings

The US is preparing to hit back at China's glut of cheap solar panels by targeting its allies

Scammers are using delivery apps like Instacart to swindle customers and delivery workers out of money

Revolutionary Genetics Research Shows RNA May Rule Our Genome

Renowned painter and pioneer of minimalism Frank Stella dies at 87

Alpacas are the only mammals known to directly inseminate the uterus

CCTV Cambridge, Addressing Digital Equity in Massachusetts

Nearly 300 people arrested at campus protests against the war in Gaza this weekend

11 movies to check out on Hulu this May

Two seconds of hope for fusion power

A Boston Cop Killer or a Victim of Framing? What to Know About Karen Read’s Murder Trial

Meme Stock Guru Roaring Kitty Reappears And It’s Blast Off For GameStop, AMC Entertainment

Share this page

Guest Posts by Easy Branches

Premium Escort Website Platform: The Perfect Blend

Nourishing the Mind: The Role of Nutrition and Exe

Introducing AI and Machine Learning to Kids

all our websites